Disc Medicine reports APOLLO Phase 3 trial success
The company says bitopertin met all primary and secondary endpoints in the pivotal APOLLO trial in adults and adolescents with erythropoietic protoporphyria.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.